Loading financials from SEC filings…
Software - Application · Technology · Fiscal year ends Jan 31
UiPath reported revenue of $1.6B in the fiscal year ended Jan 2026, up 12.7% from the year before. Operating income was $57M, an operating margin of 3.5%, and net income was $282M. Operating cash flow of $371M less capital expenditure of $19M left free cash flow of $352M.
Ranks among the 85 software - application companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 892 | 1,059 | 1,308 | 1,430 | 1,611 |
| Cost of revenue | 169 | 180 | 196 | 247 | 271 |
| Gross profit | 723 | 879 | 1,112 | 1,183 | 1,340 |
| Research & development | 277 | 286 | 332 | 381 | 385 |
| Selling, general & admin | 948 | 941 | 945 | 965 | 898 |
| Operating income | −501 | −348 | −165 | −163 | 56.8 |
| Pre-tax income | −511 | −318 | −75.8 | −78.1 | 101 |
| Income tax | 14.7 | 10.8 | 14.1 | −4.4 | −182 |
| Net income | −526 | −328 | −89.9 | −73.7 | 282 |
| Diluted EPS | −1.16 | −0.60 | −0.16 | −0.13 | 0.52 |
| Diluted shares | 455 | 548 | 564 | 560 | 545 |
| Fiscal year | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | 1,769 | 1,402 | 1,062 | 879 | 871 |
| Receivables | 252 | 374 | 436 | 451 | 488 |
| Current assets | 2,277 | 2,344 | 2,580 | 2,339 | 2,244 |
| Net PP&E | 17.2 | 29.0 | 24.0 | 32.7 | 46.0 |
| Goodwill | 53.6 | 88.0 | 89.0 | 87.3 | 125 |
| Total assets | 2,572 | 2,735 | 2,955 | 2,865 | 3,179 |
| Payables | 11.5 | 8.9 | 3.4 | 33.2 | 10.2 |
| Deferred revenue | 297 | 398 | 487 | 569 | 604 |
| Current liabilities | 528 | 626 | 712 | 799 | 905 |
| Total liabilities | 651 | 815 | 939 | 1,020 | 1,097 |
| Shareholders' equity | 1,922 | 1,920 | 2,016 | 1,846 | 2,083 |
| Backlog (remaining obligations) | 683 | 894 | 1,160 | 1,243 | 1,475 |
| Fiscal year | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Operating cash flow | −55.0 | −10.0 | 299 | 321 | 371 |
| Capital expenditure | 8.9 | 23.8 | 7.3 | 14.9 | 19.0 |
| Free cash flow | −63.8 | −33.8 | 292 | 306 | 352 |
| Depreciation & amortisation | 14.7 | 18.7 | 22.6 | 17.2 | 17.0 |
| Stock-based compensation | 516 | 370 | 372 | 358 | 291 |
| Acquisitions | 5.5 | 29.5 | 0.0 | 0.0 | 24.8 |
| Share buybacks | 0.0 | 0.0 | 103 | 391 | 329 |
| Fiscal year | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 18.6% | 23.6% | 9.3% | 12.7% |
| Gross margin | 81.1% | 83.0% | 85.0% | 82.7% | 83.2% |
| Operating margin | −56.1% | −32.9% | −12.6% | −11.4% | 3.5% |
| Net margin | −58.9% | −31.0% | −6.9% | −5.2% | 17.5% |
| Return on equityBlank when equity is negative | −27.3% | −17.1% | −4.5% | −4.0% | 13.6% |
| ROCEEBIT ÷ (assets − current liabilities) | −24.5% | −16.5% | −7.3% | −7.9% | 2.5% |
| Free cash flow margin | −7.2% | −3.2% | 22.3% | 21.4% | 21.9% |
| Cash conversion (CFO ÷ net income) | 0.10x | 0.03x | −3.33x | −4.35x | 1.31x |
| Receivable days | 103 | 129 | 122 | 115 | 111 |
| Payable days | 25 | 18 | 6 | 49 | 14 |
| Current ratio | 4.32x | 3.74x | 3.63x | 2.93x | 2.48x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.